CLINICAL_TRIALS
trial_result
· 2020-03-30
Clinical Trial Update: Osteoarthritis Knee Pain Relief Study of 0.25% 920-CGS-200 [Phase 4]
Summary
Phase 4 trial of a 0.25% topical 920-CGS-200 for knee pain relief in osteoarthritis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Propella Therapeutics | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED | Results posted: 2020-03-30